Riskpilot← Back to searchSign inGet full accessTYRIVEGEN 1,5,9 OG 13 AS
ASActiveOrg 922735158Lørenveien 73B, 0585 OsloDevelopment of building projects · NACE 6812Est. 20190 employees
Revenue 2023
NOK 0
EBITDA margin
—
-129% vs 2022
Equity ratio
-5.6%
Financial strength
Net profit 2023
NOK -591K
-111% vs 2022
| Revenue | NOK 0 | — |
| EBITDA | NOK -329K | -129% |
| Net profit | NOK -591K | -111% |
| Total assets | NOK 31,3M | +17% |
| Equity | NOK -1,8M | -50% |
| Employees | 0 | — |
Legal name
TYRIVEGEN 1,5,9 OG 13 AS
Org number
922735158
Legal form
Aksjeselskap
NACE code
6812 · Development of building projects
Founded
10. mai 2019
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Selskapet skal eie tyrivegen 1,5,9 og 13 og sammen med andre utvikle disse eiendommene for salg. Selskapet kan også engasjeres i annen virksomhet med økonomisk formål.
Address
Lørenveien 73B, 0585 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −18 | −92 | −244 | −144 | −329 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −18 | −92 | −244 | −144 | −329 |
| Net financials | −61 | −139 | −442 | −136 | −261 |
| Profit before tax | −79 | −231 | −686 | −280 | −591 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −79 | −231 | −686 | −280 | −591 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 6 357 | 5 834 | 17 774 | 26 801 | 31 333 |
| Equity | 21 | −210 | −896 | −1 176 | −1 766 |
| Long-term debt | 5 934 | 6 016 | 4 601 | 5 073 | 8 327 |
| Short-term debt | 402 | 28 | 14 070 | 22 904 | 24 773 |
| Total debt | 6 335 | 6 044 | 18 670 | 27 977 | 33 100 |
EBITDA margin
-32933500.0%
This company
15.8%
Market median
-208439973% vs market
20192023
Equity ratio
-5.6%
This company
38.2%
Market median
-115% vs market
20192023
Return on equity
-59062100.0%
This company
18.4%
Market median
-320989774% vs market
20192023
Net profit margin
-59062100.0%
This company
8.1%
Market median
-729161828% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
18.74×
This company
0.62×
Market median
-2923% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-04-25 – 2019-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Indsin Invest As
TYRIVEGEN 1,5,9 OG 13 AS Board members of TYRIVEGEN 1,5,9 OG 13 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inderjeet Singh | Chairman | 0 companies |